Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands
W J Valentine, J Jendle, M Saraheimo, B Thorsteinsson, R F Pollock, M Lammert
Dive into the research topics of 'Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands'. Together they form a unique fingerprint.